Dr. Nidhi Jalan-Sakrikar, Ph.D., is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, with a joint appointment in the Department of Biochemistry & Molecular Biology. She leads an independent research program focused on immune-mediated mechanisms that drive inflammation and fibrosis in PSC, a chronic cholestatic liver disease characterized by progressive bile duct injury.

Consultant hepatologist at Hospital Clinic Barcelona, Associate professor at University of Barcelona

Dr. Craig Lammert is an Associate Professor of Medicine at Indiana University and an adult hepatologist specializing in autoimmune liver diseases, with a particular focus on autoimmune hepatitis (AIH). His clinical and translational research program centers on advancing the understanding of AIH through studies involving genetics, biomarkers, autoantibodies, and high-dimensional proteomic platforms. He is an active clinical investigator dedicated to improving therapeutic development and clinical trial design in AIH.

İmran Hasanoğlu is a Professor of Infectious Diseases and Clinical Microbiology at Ankara Yıldırım Beyazıt University School of Medicine and works at Ankara Bilkent City Hospital, Türkiye. She serves as General Secretary of the Viral Hepatitis Society of Türkiye (VHSD), Chair of the Transplant Infections Study Group of the Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK NICG), Education Officer of the ESCMID Study Group for Viral Hepatitis (ESGVH), a Steering Committee Member of the AASLD Hepatitis C SIG, and a mentor in the ESCMID Mentorship Program.

Dr. Yao-Chun (Holden) Hsu is currently Professor of Medicine at I-Shou University, and also the Director of the Department of Medical Research at E-Da Hospital in Kaohsiung, Taiwan. Beyond his dedication to front-line patient care, Dr. Hsu is committed to clinical and translational research in liver diseases, emphasizing viral hepatitis, with a special focus on chronic hepatitis B. He spearheads the hepatitis B research team at E-Da Hospital and fosters collaborations with researchers globally.

Dr. Nguyen is Professor of Medicine, a Stanford Cancer Institute member and specializes in the treatment and prevention of primary liver cancer such as hepatocellular carcinoma (HCC).

Ming-Lung Yu is the President and a Chair Professor of Kaohsiung Medical University (KMU), Taiwan. He is also an adjunct chair professor of National Sun Yat-sen University(NSYSU). Professor Yu's research interests in Hepatology, including epidemiology, natural course, risk stratification, treatment and prognosis of HBV and HCV, as well as MASLD, have led him to publish more than 550 scientific original and review articles.

Dr. Gawrieh is Professor of Medicine at Indiana University School of Medicine. His research investigates the genetic and environmental modifiers, diagnostics and therapeutics of metabolic dysfunction- and alcohol-associated steatotic liver disease.

Rebecca Wells is a Professor of Medicine with a secondary appointment in Bioengineering at the University of Pennsylvania, where she has been on the faculty for more than 20 years. She received a medical degree from Johns Hopkins University and did postdoctoral research training at Brigham and Women's Hospital/Harvard University and the Whitehead Institute. Her lab studies the intersection between the extracellular matrix and mechanics as applied to wound healing, using the liver and biliary tree as model tissues.

Binu V. John, MD, MPH, FACG, AGAF, FAASLD
Associate Professor of Medicine, University of Miami Miller School of Medicine
Chief of Gastroenterology and Hepatology, Miami VA Healthcare System
Dr. Binu John is Associate Professor of Medicine at the University of Miami Miller School of Medicine and Chief of Gastroenterology and Hepatology at the Miami VA Healthcare System. He serves as GI Lead for VISN 8, encompassing seven VA medical centers across Florida and Puerto Rico.